The trajectory of companies tied to Sildenafil's legacy presents a complex investment landscape. While the initial success generated substantial gains, generic alternatives have significantly eroded sales . https://bookmarkinglive.com/story22703210/copyright-s-flagship-product-and-the-pharmaceutical-sector-a-uncertain-venture